baber/WOPTO huggingface dataset:
Patent NZ-314678-A (NZ)
Title: Diosmetin acids, flavone derivatives and pharmaceutical compositions thereof
Inventor: WIERZBICKI MICHEL
IPC: C07D407/12
Filed: 1997-04-24
Abstract: Diosmetin acids and esters of formula (I), their enantiomers and salts are new. R2, R4, R6 = H, 1-5C alkyl, CH2CH=CH2, CH2C(CH3)=CH2, CH2CH=C(CH3)2, CH2CH2CH(CH3)2, 2,2-dimethyl-1,3-dioxolan-4-ylmethyl, CH2CH(OH)CH2OH or ACOOR8; A = 1-3C hydrocarbon chain (optionally substituted by methyl or OH); R8 = H or 1-5C alkyl; R3, R5 = H, CH2CH2CH3, CH2CH=CH2, CH2CH(CH3)2, C(CH3)2CH=CH2, C(CH3)2CH2CH3, CH2C(CH3)=CH2 or COCH3 R1, R7 = H, CH2CH2CH3, CH2CH=CH2, CH2CH=C(CH3)2, tert.-butyl, CH2CH2CH(CH3)CH3, CH2C(CH3)=CH2 or CH2CH(CH3)2 provided that if one or two of R2, R4, and R6 = ACOOR8, then at least one of the remaining R1-R7 is not H.
Patent NZ-314719-A (NZ)
Title: Determining the papermaking properties of a fibre suspension by determining the diffusion rate of a tracer through the walls of the fibres
Inventor: SILENIUS PETRI
IPC: G01N33/34
Filed: 1997-05-01
Abstract: The invention relates to a procedure for determining a quantity dependent on the rate of diffusion in the fibre wall for diffusion occurring through it, in which procedure a diffusible tracer is introduced into the fibres under measurement, the fibres are suspended in an aqueous phase and the tracer concentration is determined after a certain time has elapsed since the time of suspension of the fibres, and the quantity dependent on the rate of diffusion is calculated on the basis of the concentration and time. <??>In addition, the invention relates to a procedure for determining the proportion of secondary fibre in a fibre suspension containing primary fibre and secondary fibre, in which procedure virtual diffusion coefficients are determined in the fibre wall for diffusion taking place through it in at least two fibre suspensions for which the proportions of primary and secondary fibre are known and in a fibre suspension under measurement, and that the proportion of secondary fibre in the suspension under measurement is estimated by assuming that the diffusion coefficient depends mainly linearly on the proportion of primary and secondary fibre in the fibre suspension. <IMAGE>
Patent NZ-330850-A (NZ)
Title: An assembly for connecting a toilet seat hinge support to a toilet pan bolt comprises an offset bolt head and hinge support with biasing means
Inventor: DUNSTAN PETER ROSS
IPC: A47K13/26
Filed: 1998-07-02
Abstract: n assembly for connecting a toilet seat hinge support 42 to a toilet pan bolt 44 is claimed.  Bolt 44 comprises a threaded shank 46 and an offset cylindrical head 48 having an engaging formation 50.  Hinge support 42 includes a base 52 with a cylindrical bore 54 and a complementary engaging formation.  Bore 54 is adapted to receive offset cylindrical head 48 therein.  The connecting assembly includes a biasing means 38 adapted to bias engaging formation 50 of bolt 44 into engagement with the complementary engaging formation of hinge support 42 to thereby releasably connect bolt 44 to hinge support 42.
Patent NZ-335932-A (NZ)
Title: Use of a peptide agent such as a diphosphorylated peptide to modulate the interactions between myosin and integrins
Inventor: JENKINS ALISON L
IPC: A61P21/02
Filed: 1997-11-21
Abstract: A method for identifying an agent, which modulates the interaction of an integrin with myosin, comprises the steps of: a) incubating a peptide comprising the phosphorylated cytoplasmic domain of the b-subunit of the integrin with myosin and with the agent, and b) determining whether the agent modulates the binding of myosin to the peptide. An agent that modulates the interaction of myosin and integrin is used in the manufacture of a medicament for modulating the direct interaction of an integrin with myosin in a cell. An agent that blocks the bonding of integrin to myosin is used in the manufacture of a medicament to block the direct interaction of an integrin with myosin such as reducing the severity of a pathological state mediated by direct integrin attachment to myosin. The agent can be a peptide sequence derived from the cytoplasmic domain of an integrin wherein the tyrosine residues are phosphorylated such as a diphosphorylated peptide corresponding to residues 740-762 of b3-subunit having the following sequence:  Biotin-D-T-A-N-N-P-L-Y(PO3)-K-E-A-T-S-T-F-T-N-I-T-Y(PO3)-R-G-T-COOH (peptide 1).
Patent NZ-506882-A (NZ)
Title: Improvement to spray valve
Inventor: SHACKLETON BLAIR
IPC: B05B12/00
Filed: 2000-09-26
Abstract: An adjustable spray valve (1), for the controlled spraying of a variable condition surface such as a road. The spray valve includes a main body (2) and an inner sleeve (3) , the inner sleeve being configured so that relative movement of the inner sleeve adjusts the flow rate of the spray valve.
Patent NZ-508082-A (NZ)
Title: Reversible self-adhesive label for use on inside of windscreen or on outside of trailer
Inventor: MCKENZIE NICOLE MAREE
IPC: G09F3/10
Filed: 2000-11-10
Abstract: The label is constructed so that it can be adhered to the inside of a windscreen by removal of layer 2. Alternatively, it can be adhered to a trailer by removal of layer 7.
Patent NZ-514379-A (NZ)
Title: Synthesis of 3-amino-3-aryl propanoates
Inventor: ABDEL-MAGID AHMED F
IPC: C07D213/55
Filed: 2000-03-21
Abstract: A process for the synthesis of a compound of formula (I) wherein R1 is aryl, heteroaryl, substituted aryl or substituted heteroaryl and R2 is hydrogen, alkyl or aralkyl, or salt thereof.
Patent NZ-515997-A (NZ)
Title: Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
Inventor: ALAUX GERARD
IPC: A61K47/24
Filed: 2000-06-27
Abstract: A timed dual release dosage form comprises a short acting hypnotic or a salt thereof and is adapted to release the short acting hypnotic over a predetermined time period, according to an in vitro profile of dissolution when measured in a rotating paddle apparatus of the European pharmacopoeia in 0.01M hydrochloric acid buffer at 37oC, comprising two release pulses. The first release pulse is immediate having a maximum duration of 30 minutes and the second release pulse is delayed by a fixed time of between 50 to 200 minutes after the administration. The delayed second release pulse lasts between 30-200 minutes. The short acting hypnotic can be triazolam, temazepam, brotizolam, zopiclone, (R)-zopiclone, zaleplon, alimemazine or zolpidem.
Patent NZ-516263-A (NZ)
Title: A material comprising self-aligning peptides modeled on human elastin for cosmetic material or a prosthesis
Inventor: ROTHSTEIN ASER
IPC: A61L31/10
Filed: 2000-06-29
Abstract: A polypeptide comprises a minimal functioning unit (MFU) and is comprised of at least three beta-sheet/beta-turn structures and at least one amino acid residue that participates in cross-linking and is not a naturally occurring fibrous protein. The MFU is selected from amino acid residues 374-499 of Figure 1B (SEQ ID NO:1), the sequence set forth in Figure 5A (SEQ ID NO:9), the sequence set forth in Figure 5B (SEQ ID NO:10) and the sequence set for the in Figure 5C (SEQ ID NO:11). A cosmetic material and a prosthesis can comprise the polypeptide. Also described is a method for producing the polypeptides comprising (a) expressing in a cell a polypeptide comprising (i) a first domain that enhances the solubility of the polypeptide, (ii) a second domain that comprises at least three beta-sheet/beta-turn structures and at least one amino acid residue that participates in cross-linking and that is not a naturally occurring protein wherein the N-terminus of the second domain comprises a proline residue, (iii) an aspartic acid residue positioned between the domains wherein the aspartic acid residue forms a peptide bond with the proline residue, (b) harvesting the cell and then (c) treating the cell with a weak acid , wherein the weak acid cleaves the polypeptide at each occurrence of an aspartic acid-proline peptide bond.
Patent NZ-516462-A (NZ)
Title: Improvements to trailer braking systems
Inventor: CLAERHOUT MICHAEL CLARENCE
IPC: B60T7/20
Filed: 2000-06-23
Abstract: A system for effecting a braking force on a towed vehicle, the system including at least one braking sensor located on a towing vehicle, a control unit for communication with a braking actuator mechanism located on the apparatus towed by the towing vehicle, the system characterized in that the control unit can determine braking force sensed by the braking sensor and signal braking actuator mechanism to apply a braking force to a towed vehicle proportional to the force applied to the braking sensor as determined by the control unit.
Patent NZ-520327-A (NZ)
Title: Use of human immunodeficiency virus proteins in vaccines
Inventor: VOSS GERALD
IPC: A61K39/00
Filed: 2001-01-29
Abstract: Use of a) an HIV Tat protein or polynucleotide; or b) an HIV Nef protein or polynucleotide; or c) an HIV Tat protein or polynucleotide linked to an HIV Nef protein or polynucleotide and an HIV gp120 protein or polynucleotide in the manufacture of a vaccine for the prophylactic or therapeutic immunization of humans against HIV, wherein the Tat, Nef or Nef-Tat act in synergy with gp120 in the treatment or prevention of HIV.
Patent NZ-526863-A (NZ)
Title: Method of producing a refolded inactive HCV NS2/3 protease
Inventor: THIBEAULT DIANE
IPC: C12N7/01
Filed: 2001-12-13
Abstract: Described is a method for producing a refolded, inactive form of recombinantly produced NS2/3 protease, which comprises the steps of: a) purifying the protease from inclusion bodies in the presence of a chaotropic agent; and b) refolding the purified protease by contacting it with a reducing agent and lauryldiethylamine oxide (LDAO) in the presence of reduced concentration of chaotropic agent or polar additive. Also described is a method for activating this refolded inactive NS2/3 protease by adding an activation detergent. This method produces large amounts of the active NS2/3 protease to allow small molecules and ligands to be screened as potential inhibitors of NS2/3 protease, which may be useful as therapeutic agents against HCV.
Patent NZ-535067-A (NZ)
Title: Markup language data structure
Inventor: BEDA JOSEPH S
Filed: 2003-05-14
Abstract: A data structure stored on a computer-readable medium comprises: a first set of data comprising a first set of tags and property data, in which the context in which the first set of tags is interpreted indicates that the first set of tags is directed to an element level; a second set of data comprising a second set of tags and second property data, in which the context in which the second set of tags is interpreted corresponds to complex property syntax and indicates that the second set of tags is directed to a resource level. When the data structure is interpreted, the first set of data results in data corresponding to the first set of tags being created and inserted into an element-level tree based on the first information in the first set of text tags, and the second set of data results in data corresponding to the second set of tags being provided to directly create a scene graph object in a scene graph data structure at the resource level via an interface to the scene graph data structure, based on the second information in the second set of text tags.
Patent NZ-535728-A (NZ)
Title: A pipe fitting and method of manufacturing a pipe fitting
Inventor: MCMAHON MICHAEL PAUL
Filed: 2004-10-04
Abstract: A method of manufacturing a pipe fitting comprising the steps of: (a) manufacturing one or more body components of a pipe fitting; (b) manufacturing one or more collar components of a pipe fitting; (c) attaching or mounting each collar component to a body component while the collar component retains resilience due to the manufacturing process of the collar component, so that each body component carries at least one collar component. A pipe fitting made by the method is also disclosed.
Patent NZ-535746-A (NZ)
Title: Chewing gum in powder form and a method of preparation
Inventor: SOZZI GIUSEPPE
IPC: A23G4/04
Filed: 2003-04-04
Abstract: 1. Method of producing chewing gum in powder form, comprising the following steps: a) mixing of a soft basic chewing gum with at least one sweetener and, optionally, at least one other typical chewing gum ingredient, at a temperature of between about 35 and 75°C, b) cooling the mixture thus obtained to a temperature of between about 0 and -40°C, c) grinding and subsequent screening of the mixture thus obtained to give a powder having a particular size less than about 10 mesh, d) mixing the powder thus obtained with at least one anti-agglutination agent, e) optional mixing of the powder thus obtained with one or more of sweeteners, flavourings, colourings, food acids, and other additives, f) optional compression of the mixture thus obtained.
Patent NZ-536662-A (NZ)
Title: Apparatus, method, and compositions for adding fragrance to laundry
Inventor: CONLEY SAMUEL G
IPC: D06F58/20
Filed: 2003-05-22
Abstract: An apparatus for dispensing a fragrance onto laundry in a dryer without substantial loss of that fragrance during the drying process. The apparatus includes an electrostatic vapour generator capable of dispensing a fragrance composition into a dryer.
Patent NZ-539192-A (NZ)
Title: Sustained release composition for oral administration of drugs
Inventor: WOO JONG-SOO
IPC: A61P31/04
Filed: 2003-10-23
Abstract: Disclosed is a sustained release composition for oral administration of a drug, comprising: a carrier for sustained release of the drug comprising a mixture of sodium alginate and xanthan gum, a gel hydration accelerator comprising a mixture of hydroxypropyl methylcellulose and propylene glycol alginate.
Patent NZ-541863-A (NZ)
Title: Fire-retardant mattress
Inventor: GLADNEY RICHARD F
IPC: A47C27/00
Filed: 2004-02-17
Abstract: A fire barrier fabric quilted under ticking material of a bedding product. This specific mattress design improves resistance to fire damage to the mattress and surroundings and reduces the generation of harmful smoke. Adding this fire barrier fabric to the quilt panel does not compromise the intended use of the end use product. The bedding products can also improve the fire resistance of the border panel of a mattress. The fire barrier fabric is placed directly behind the standard ticking material and can be applied to all standard bedding sizes.
Patent NZ-544410-A (NZ)
Title: Anti-ngf antibodies for the treatment of various disorders
Inventor: SHELTON DAVID L
IPC: A61P19/02
Filed: 2002-05-09
Abstract: Disclosed is the use of an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range and inhibiting the binding of hNGF to human TrKA in vivo in the manufacture of a medicament for controlling an NGF-related disorder in a human patient. NGF-related disorders include asthma, arthritis, rheumatoid arthritis, psorasis, multiple sclerosis and lupus erthematosus. (62) Divided Out of 529612
Patent NZ-553751-A (NZ)
Title: Cap for drug delivery devices
Inventor: TSUBOTA JUN
IPC: A61M5/32
Filed: 2005-09-10
Abstract: The disclosure relates to a cap for drug delivery devices, in particular of the injector-type comprising a needle and a needle cover, wherein said cap is suitable as a needle safety tool, by comprising a needle cover retaining portion. In particular, the present disclosure relates to such devices, which are handled by the patients themselves.
Patent NZ-554080-A (NZ)
Title: Protein system and food products including same
Inventor: COLEMAN EDWARD C
IPC: A23L29/281
Filed: 2007-03-23
Abstract: Disclosed is a food product comprising a moisture source, partially hydrolyzed dairy protein, partially hydrolyzed legume protein, intact dairy protein, and intact legume protein, wherein the total amount of partially hydrolyzed dairy protein and partially hydrolyzed legume protein comprises about 1 to about 40 weight % of the protein-containing component and, wherein the partially hydrolyzed dairy protein and partially hydrolyzed legume protein are present in a total amount effective to reduce firmness of the food product during shelf life relative to an otherwise identical food product which substitutes intact forms of the partially hydrolyzed dairy protein and partially hydrolyzed legume protein therefor, and without embittering the food product.
Patent NZ-562996-A (NZ)
Title: Protein glycosylation
Inventor: DAVIS BENJAMIN GUY
IPC: C07K1/107
Filed: 2006-04-06
Abstract: Disclosed is a method of glycosylating a protein wherein the method comprises the steps of i) modifying a protein to include an alkyne and/or an azide group; and ii) reacting the modified protein in (i) with (a) a carbohydrate moiety modified to include an azide group; and/or (b) a carbohydrate moiety modified to include an alkyne group in the presence of a Cu(I) catalyst, wherein said Cu(l) catalyst is provided in a solvent in the presence of a stabilising ligand.
Patent NZ-577473-A (NZ)
Title: Detecting erroneous retransmissions by using a stored order of the requests for retransmissions using an error detection method
Inventor: TIMNER YLVA
IPC: H04L1/18
Filed: 2007-02-07
Abstract: A node for use as a User Equipment (UE) and a Radio Base Station (RBS) in a cellular access system, and a method for use in a cellular system is disclosed. The node for use as a Radio Base Station (RBS) in a cellular access system controls traffic to and from a cell in the system where there is at least one user with a User Equipment (UE) in the cell. The RBS comprises means for receiving and transmitting information to and from the UE, so that the RBS can be either the sending party or the receiving party with respect to the UE. The RBS comprises first means for detecting errors in messages which are received from the UE by an error detection method. The RBS comprises means for requesting the UE to retransmit a message in which an error has been detected where the RBS comprises means for storing a sequence of requested retransmissions configured to be compared to a sequence of received retransmissions, by means of which erroneous retransmissions may be detected by retransmission error detection means without the aid of the first error detection means, following which the RBS may request a retransmission from the UE of the erroneously received retransmission.
Patent NZ-577636-A (NZ)
Title: Hair styling and frizz controlling composition
Inventor: VERBOOM GILLES
IPC: A61K8/81
Filed: 2007-12-13
Abstract: Disclosed is a hair-styling composition comprising polyvinylpyrrolidone, at least one nonionic vinylpyrrolidone copolymer comprising N-vinylpyrrolidone, methacrylamide and Nvinylimidazole monomeric units, at least one cellulosic polymer comprising cationic substituents derived from the polymerization or oligomerization of dimethyl diallyl ammonium chloride, at least one thickener, which includes an acrylates/beheneth-25 acrylate copolymer, a PEG-180/Dodoxynol-5/PEG-25 tristyrylphenol/tetramethoxy-methylglycouril copolymer, and water wherein the composition includes no more than about 0.5 wt per cent carbomer and, when applied to human hair, exhibits at least about 80 per cent curl retention after about 2 hours under conditions of about 85 per cent relative humidity and about 75 degrees F (24 degrees C).
Patent NZ-586904-A (NZ)
Title: Microwavable dough formulation and packaging therefor
Inventor: NILSSON URBAN
IPC: A21D2/18
Filed: 2009-01-19
Abstract: Discloses a ready-to-use, microwavable dough formulation comprising a flour mixture of (a) a gluten-containing flour and (b) a low-gluten flour or a starch component. The weight ratio of the flour components (a)/(b) is greater than 2:1. The formulation further comprises sugar, water and a spread-controlling agent. The spread-controlling agent comprises a cellulose component, a pre-gelatinized starch, and a humectant. The spread-controlling agent components are in combined amount that: (i) the spread-controlling agent is effective to impart water retention to the dough formulation and (ii) the spread-controlling agent is at less than about 10% by weight so that spreading of the dough formulation during microwave baking is controlled. Further discloses method of microwave baking which comprises associating the disclosed dough formulation in contact with at least a portion of a susceptor material configured to provide optimal heat distribution during microwave baking of the dough. The method provides for controlled spreading of the dough formulation during microwave baking to achieve baking products.
Patent NZ-591238-A (NZ)
Title: Method for producing high-purity silicon carbide from hydrocarbons and silicon oxide through calcination
Inventor: LANG JURGEN ERWIN
IPC: C04B35/565
Filed: 2009-09-28
Abstract: Disclosed herein is a high-purity composition comprising silicon carbide and carbon and silicon dioxide, having an impurity profile in respect of boron and phosphorus, wherein the boron content is in the range from 10 ppm to 0.001 ppt and the phosphorus content is in the range from 20 ppm to 0.001 ppt. Also disclosed is the use of said high-purity composition in the production of silicon or in the preparation of silicon carbide from pyrolysis of carbon and silicon dioxide at elevated temperatures.
Patent NZ-591727-A (NZ)
Title: Liquid active ingredient concentrates that can be emulsified in water
Inventor: KRAPP MICHAEL
IPC: A01P13/00
Filed: 2009-09-25
Abstract: The disclosure relates to liquid active ingredient concentrates that can be emulsified in water, said concentrates comprising at least a herbicidal dinitroaniline, in particular pendimethalin, and at least an imidazolinone herbicide, in particular Imazomax. The disclosed liquid, water-emulsifiable active ingredient concentrate comprises: (a) 100 to 400 g/l of at least one herbicidal dinitroaniline (component a); (b) 5 to 100 g/l of at least one imidazolinone herbicide in the form of the ammonium salt or substituted ammonium salt thereof (component b); (c) 20 to 100 g/l water (component c); (d) 15 to 150 g/l of at least one anionic surface active substance comprising at least one sulfonic acid group in the form of the sodium, potassium, ammonium or substituted ammonium salt of said surface active substance, (component d); (e) 5 to 100 g/l of at least one polymeric, non-ionic surface active substance comprising at least a polyethylene oxide group and at least a radical selected from poly-C3-C4-alkylene oxide groups (component e); (f) 50 to 250 g/l of at least one non-ionic surface active substance selected from ethoxylated fatty acid esters of polyhydroxyl compounds, alkylpolyglucosides, ethoxylated C4-C16 alkyl phenols and ethoxylated C8-C22- alkanols (component f); (g) at least one hydrocarbon solvent to make 1 Iiter (component g); wherein the amounts of components (a) to (f) indicated in g/l are based on the total volume of the active ingredient concentrate.
Patent NZ-594215-A (NZ)
Title: New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
Inventor: KHULLAR PRAVEEN
IPC: A61K31/192
Filed: 2009-01-22
Abstract: 594215 Disclosed is a pharmaceutical composition in the form of a solid dosage form containing a combination of granulated ketoprofen (non-steroidal anti-inflammatory drug NSAID) and granulated thiocolchicoside (colchicoside derivative), the active ingredients being present in the free state or in the form of a salt , wherein the ketoprofen and thicolchicoside are granulated separately prior to combination in the tablet. Also disclosed is the method of preparing the composition and the use of the composition in the manufacture of a medicament for ameliorating and/or treating musculoskeletal and joint disorders, peri-articular disorders and painful muscle spasm.